Sugi Predict

Sugi Predict / Compounds / SCHEMBL30952784

SCHEMBL30952784

SCHEMBL30952784

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.63

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 9/20 0.61
▸ NPY1R P25929 6/20 0.61
▸ NPY2R P49146 4/20 0.61
▸ NPY5R Q15761 4/20 0.61
▸ TFPI P10646 1/20 0.59
▸ KISS1R Q969F8 6/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31180467 0.91 NPY4R (0.68) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL6470860 0.90 NPY4R (0.72) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL6470874 0.90 NPY4R (0.72) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL15929733 0.88 NPY4R (0.63) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL31222373 0.87 NPY4R (0.68) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30537834 0.87 TFPI (0.60) NPY4RNPY1RNPY2RNPY5RTFPI
SCHEMBL6471470 0.87 NPY4R (0.64) NPY4RNPY1RNPY2RNPY5RTFPI
SCHEMBL6471476 0.87 NPY4R (0.64) NPY4RNPY1RNPY2RNPY5RTFPI
SCHEMBL30008293 0.87 NPY4R (0.60) NPY4RNPY1RNPY2RNPY5RTFPI
SCHEMBL30537835 0.86 NPY4R (0.60) NPY4RNPY1RNPY2RNPY5RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642451-A2 N-MYRISTOYLTRANSFERASE INHIBITORS AND METHODS OF USE Seattle Children's Hospital d/b/a Seattle Children's Research Institute (US) 2025-11-05 — — EP disclosed
WO-2024145273-A2 N-MYRISTOYLTRANSFERASE INHIBITORS AND METHODS OF USE SEATTLE CHILDREN'S HOSPITAL (D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE) (US) 2024-07-04 — — WO disclosed
Send feedback